EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DHA-Derived Lipid Mediators Attenuate Osteoarthritis by Resolving Inflammation and Protecting Cartilage in Association with the SIRT1 Signaling Pathway

Yan Su, Soon Kyu Kwon iD, Hack Sun Choi, Yunjon Han, Jung-Hee Park iD, Jong Hyun Choi, Jeong-Woo Seo iD

Marine Drugs · 12.06.2026 · 24 (6) · 209

DOI: 10.3390/md24060209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 12.06.2026. Verfasst von Yan Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181 Ipsin-gil, Jeongeup-si 56212, Republic…. Hauptthemen laut MEDLINE: Sirtuin 1, Osteoarthritis, Docosahexaenoic Acids, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of SMEs and Startups, the National Research Foundation of Korea government, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by persistent low-grade inflammation and progressive cartilage destruction. Macrophage-driven inflammatory responses contribute to extracellular matrix (ECM) degradation and accelerate disease progression. Here, we investigated the therapeutic potential of a DHA-derived lipid mediator mixture (LM), generated via soybean lipoxygenase and composed of 17S-hydroxydocosahexaenoic acid, resolvin D5, and protectin DX (3:47:50), in regulating macrophage–chondrocyte crosstalk and OA progression. LM significantly reduced IL-6, IL-1β, and TNF-α production in lipopolysaccharide-induced THP-1 macrophages. Conditioned medium from LM-treated macrophages attenuated ECM degradation in primary chondrocytes by suppressing MMP13 and ADAMTS5 while restoring COL2A1 and ACAN expression, indicating that LM may indirectly protects ECM by modulating the inflammatory microenvironment. In parallel, LM directly protected chondrocytes against IL-1β-induced inflammatory and catabolic responses, and restored ECM homeostasis. Mechanistically, LM significantly increased SIRT1 expression and deacetylation activity, as demonstrated by reduced NF-κB p65 acetylation. Both pharmacological inhibition by EX527 and siRNA-mediated SIRT1 knockdown abolished the protective effects of LM on ECM preservation. In vivo, LM oral administration alleviated cartilage destruction, improved joint structure and suppressed OA progression in a monosodium iodoacetate-induced OA model. Notably, micro-CT studies have demonstrated that LM significantly improved subchondral bone architecture, as evidenced by increased bone volume fraction and improved trabecular parameters. Histological analyses confirmed that LM attenuated inflammation and maintained cartilage integrity. Consistently, immunohistochemical findings showed reduced MMP13 expression, restoration of collagen II and aggrecan, and upregulation of SIRT1 in the LM-treated group compared to OA rats. Collectively, these findings suggest that LM mitigates OA progression by reducing inflammation, preserving ECM homeostasis, and attenuating subchondral bone deterioration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1OsteoarthritisDocosahexaenoic AcidsInflammationAnimalsChondrocytesSignal TransductionHumansSpecialized Pro-Resolving MediatorsMaleRatsMacrophagesExtracellular MatrixRats, Sprague-DawleyCartilage, ArticularCartilageTHP-1 Cells

Stichwörter der Autor:innen

ECMMIA-induced modelchondrocytesinflammationlipid mediatorsosteoarthritis

Substanzen

Sirtuin 1Docosahexaenoic Acids

Autor:innen und Institutionen

  • Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181 Ipsin-gil, Jeongeup-si 56212, Republic of Korea.
  • Department of Biotechnology, Jeonbuk National University, Iksan 54596, Republic of Korea.
  • Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

ORCID-Profile: Soon Kyu Kwon, Jung-Hee Park, Jeong-Woo Seo

Förderung

  • the Ministry of SMEs and Startups
  • the National Research Foundation of Korea government
  • Ministry of Science and ICT
  • National Research Foundation of Republic of Korea government

Zitieren

APA

Su, Y., Kwon, S. K., Choi, H. S., Han, Y., Park, J. H., Choi, J. H., & Seo, J. W. (2026). DHA-Derived Lipid Mediators Attenuate Osteoarthritis by Resolving Inflammation and Protecting Cartilage in Association with the SIRT1 Signaling Pathway. Marine Drugs, 24(6), 209. https://doi.org/10.3390/md24060209

Vancouver

Su Y, Kwon SK, Choi HS, Han Y, Park JH, Choi JH, et al. DHA-Derived Lipid Mediators Attenuate Osteoarthritis by Resolving Inflammation and Protecting Cartilage in Association with the SIRT1 Signaling Pathway. Marine Drugs. 2026;24(6):209. doi:10.3390/md24060209

BibTeX
@article{Su2026,
  author = {Su, Yan and Kwon, Soon Kyu and Choi, Hack Sun and Han, Yunjon and Park, Jung-Hee and Choi, Jong Hyun and Seo, Jeong-Woo},
  title = {DHA-Derived Lipid Mediators Attenuate Osteoarthritis by Resolving Inflammation and Protecting Cartilage in Association with the SIRT1 Signaling Pathway},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {209},
  doi = {10.3390/md24060209}
}
Kostenlos starten →